Lp(a) lipoprotein, IgG, IgA and IgM antibodies to Chlamydia pneumoniae and HLA class II genotype in early coronary artery disease
- 1 April 1995
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 114 (2) , 165-174
- https://doi.org/10.1016/0021-9150(94)05480-7
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- INDICATIONS OF AN AUTOIMMUNE COMPONENT IN LP(a) ASSOCIATED DISORDERSEuropean Journal of Immunogenetics, 1994
- Sequence polymorphisms in the apolipoprotein (a) gene. Evidence for dissociation between apolipoprotein(a) size and plasma lipoprotein(a) levels.Journal of Clinical Investigation, 1993
- Lipoprotein(a), atherosclerosis and thrombosisProgress in Lipid Research, 1991
- Lipoprotein (a), lipids, and lipoproteins in patients with rheumatoid arthritis.Annals of the Rheumatic Diseases, 1991
- cDNA sequence of human apolipoprotein(a) is homologous to plasminogenNature, 1987
- PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTIONThe Lancet, 1987
- Lp(a) lipoprotein as a risk factor for myocardial infarctionJAMA, 1986
- Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography.Circulation, 1986
- Pre‐Beta1‐Lipoprotein in Patients with Ischemic Heart DiseaseActa Medica Scandinavica, 1981
- Confirmation of an influence of the inherited Lp(a) variation on serum insulin and glucose levelsClinical Genetics, 1979